223 related articles for article (PubMed ID: 32885029)
21. Lipid Profile and Atherogenic Risk Assessment in Nigerian Breast Cancer Patients - A Cross-Sectional Study.
Izuegbuna OO; Olawumi HO; Agodirin OS; Olatoke SA
J Am Nutr Assoc; 2024 May; ():1-10. PubMed ID: 38805002
[TBL] [Abstract][Full Text] [Related]
22. Can atherogenic indices and the triglyceride-glucose index be used to predict erectile dysfunction?
Sambel M; Erdogan A; Caglayan V; Avci S; Kilic S; Yildiz HE; Keskin E
Sex Med; 2023 Dec; 11(6):qfad069. PubMed ID: 38250336
[TBL] [Abstract][Full Text] [Related]
23. Association between nontraditional lipid profiles and the severity of obstructive sleep apnea: A retrospective study.
Fang Y; Su J; Zhao C; Meng Y; Wei B; Zhang B; Huang Y; Dai L; Ouyang S
J Clin Lab Anal; 2023 Sep; 37(17-18):e24499. PubMed ID: 35576500
[TBL] [Abstract][Full Text] [Related]
24. The correlation between atherogenic indexes and erectile dysfunction.
Culha MG; Canat L; Degirmentepe RB; Albayrak AT; Atalay HA; Merder E; Ariman A; Altunrende F
Aging Male; 2020 Dec; 23(5):1232-1236. PubMed ID: 32266853
[TBL] [Abstract][Full Text] [Related]
25. Impact of TNF-α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the Catholic Axial Spondyloarthritis COhort (CASCO).
Min HK; Lee J; Ju JH; Park SH; Kwok SK
Clin Rheumatol; 2020 Feb; 39(2):471-477. PubMed ID: 31486930
[TBL] [Abstract][Full Text] [Related]
26. The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study.
González-Juanatey JR; Cordero A; Castellano JM; Masana L; Dalmau R; Ruiz E; Sicras-Mainar A; Fuster V
Int J Cardiol; 2022 Aug; 361():116-123. PubMed ID: 35569611
[TBL] [Abstract][Full Text] [Related]
27. Is non-high-density lipoprotein associated with metabolic syndrome? A systematic review and meta-analysis.
Mardi P; Abdi F; Ehsani A; Seif E; Djalalinia S; Heshmati J; Shahrestanaki E; Gorabi AM; Qorbani M
Front Endocrinol (Lausanne); 2022; 13():957136. PubMed ID: 36176470
[TBL] [Abstract][Full Text] [Related]
28. Difference in the Standard and Novel Lipid Profile Parameters Between Patients With Alzheimer's Disease and Vascular Dementia Stratified by the Degree of Cognitive Impairment.
Zaciragic A; Dervisevic A; Valjevac A; Fajkic A; Spahic S; Hasanbegovic I; Jadric R; Lepara O
Mater Sociomed; 2022 Jun; 34(2):100-106. PubMed ID: 36199842
[TBL] [Abstract][Full Text] [Related]
29. Combined superposition effect of hypertension and dyslipidemia on left ventricular hypertrophy.
Zhang X; Li G; Shi C; Zhang D; Sun Y
Animal Model Exp Med; 2022 Jun; 5(3):227-238. PubMed ID: 35746831
[TBL] [Abstract][Full Text] [Related]
30. The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape.
Bage IJ; Kamalanathan S; Selvarajan S; Sahoo J; Jayanthi M; Naik D
Cureus; 2023 Sep; 15(9):e45985. PubMed ID: 37900537
[TBL] [Abstract][Full Text] [Related]
31. Plasma Homocysteine Level Is Independently Associated With Conventional Atherogenic Lipid Profile and Remnant Cholesterol in Adults.
Zhou L; Liu J; An Y; Wang Y; Wang G
Front Cardiovasc Med; 2022; 9():898305. PubMed ID: 35770226
[TBL] [Abstract][Full Text] [Related]
32. Association between remnant cholesterol and arterial stiffness: A secondary analysis based on a cross-sectional study.
Wang Z; Li M; Xie J; Gong J; Liu N
J Clin Hypertens (Greenwich); 2022 Jan; 24(1):26-37. PubMed ID: 34750951
[TBL] [Abstract][Full Text] [Related]
33. Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?
Tecer D; Sunar I; Ozdemirel AE; Tural R; Kucuksahin O; Sepici Dincel A; Ataman S
Adv Rheumatol; 2019 Nov; 59(1):49. PubMed ID: 31727163
[TBL] [Abstract][Full Text] [Related]
34. The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease - expert panel meeting report.
Grigorian-Shamagian L; Coca A; Morais J; Perez-Martinez P;
BMC Proc; 2023 Aug; 17(Suppl 8):20. PubMed ID: 37587509
[TBL] [Abstract][Full Text] [Related]
35. Waist Circumference as a Preventive Tool of Atherogenic Dyslipidemia and Obesity-Associated Cardiovascular Risk in Young Adults Males: A Cross-Sectional Pilot Study.
Hernández-Reyes A; Vidal Á; Moreno-Ortega A; Cámara-Martos F; Moreno-Rojas R
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33276653
[TBL] [Abstract][Full Text] [Related]
36. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the use of novel atherogenicity indices and insulin resistance surrogate markers in predicting the risk of coronary artery disease: a case‒control investigation with comparison to traditional biomarkers.
Mahdavi-Roshan M; Mozafarihashjin M; Shoaibinobarian N; Ghorbani Z; Salari A; Savarrakhsh A; Hekmatdoost A
Lipids Health Dis; 2022 Nov; 21(1):126. PubMed ID: 36435770
[TBL] [Abstract][Full Text] [Related]
38. The sensibility of the new blood lipid indicator--atherogenic index of plasma (AIP) in menopausal women with coronary artery disease.
Guo Q; Zhou S; Feng X; Yang J; Qiao J; Zhao Y; Shi D; Zhou Y
Lipids Health Dis; 2020 Feb; 19(1):27. PubMed ID: 32093690
[TBL] [Abstract][Full Text] [Related]
39. Higher atherogenic risk in schoolchildren is associated with MTMR9 rs2293855 gene polymorphism and genetic score.
Silva MA; Resende CMM; Louro MB; Ribeiro SAV; do Carmo Castro Franceschini S; Velasquez-Melendez G; Alvarez-Leite JI; Durso DF; de Novaes JF
Nutr Bull; 2023 Dec; 48(4):559-571. PubMed ID: 37905391
[TBL] [Abstract][Full Text] [Related]
40. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2012 Oct; 11():125. PubMed ID: 23057687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
